122 related articles for article (PubMed ID: 10463668)
21. Risedronate in the treatment of Murine Chagas' disease.
Bouzahzah B; Jelicks LA; Morris SA; Weiss LM; Tanowitz HB
Parasitol Res; 2005 Jun; 96(3):184-7. PubMed ID: 15844009
[TBL] [Abstract][Full Text] [Related]
22. Altered Cardiomyocyte Function and Trypanosoma cruzi Persistence in Chagas Disease.
Cruz JS; Santos-Miranda A; Sales-Junior PA; Monti-Rocha R; Campos PP; Machado FS; Roman-Campos D
Am J Trop Med Hyg; 2016 May; 94(5):1028-33. PubMed ID: 26976879
[TBL] [Abstract][Full Text] [Related]
23. Endogenous osteopontin induces myocardial CCL5 and MMP-2 activation that contributes to inflammation and cardiac remodeling in a mouse model of chronic Chagas heart disease.
Caballero EP; Santamaría MH; Corral RS
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):11-23. PubMed ID: 28987763
[TBL] [Abstract][Full Text] [Related]
24. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
25. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy.
Mukherjee S; Belbin TJ; Spray DC; Iacobas DA; Weiss LM; Kitsis RN; Wittner M; Jelicks LA; Scherer PE; Ding A; Tanowitz HB
Parasitol Res; 2003 Oct; 91(3):187-96. PubMed ID: 12910413
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory and anti-fibrotic effects of ganglioside therapy on the cardiac chronic form of experimental Trypanosoma cruzi infection.
Cutrullis RA; Poklépovich TJ; Postan M; Freilij HL; Petray PB
Int Immunopharmacol; 2011 Aug; 11(8):1024-31. PubMed ID: 21371583
[TBL] [Abstract][Full Text] [Related]
27. Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice.
Cummings KL; Tarleton RL
Infect Immun; 2004 Jul; 72(7):4081-9. PubMed ID: 15213153
[TBL] [Abstract][Full Text] [Related]
28. [Chagasic myocardiopathy: historical perspective].
Elizari MV
Medicina (B Aires); 1999; 59 Suppl 2():25-40. PubMed ID: 10668240
[TBL] [Abstract][Full Text] [Related]
29. Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease.
Molina-Berríos A; Campos-Estrada C; Lapier M; Duaso J; Kemmerling U; Galanti N; Ferreira J; Morello A; López-Muñoz R; Maya JD
Parasitol Res; 2013 Jul; 112(7):2731-9. PubMed ID: 23681190
[TBL] [Abstract][Full Text] [Related]
30. The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice.
Souza AP; Jelicks LA; Tanowitz HB; Olivieri BP; Medeiros MM; Oliveira GM; Pires AR; Santos AM; Araújo-Jorge TC
Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):746-51. PubMed ID: 20944987
[TBL] [Abstract][Full Text] [Related]
31. Effects of verapamil on acute murine Chagas' disease.
Tanowitz HB; Wittner M; Chen B; Huang H; Weiss LM; Christ GJ; Braunstein V; Bilezikian JP; Morris SA
J Parasitol; 1996 Oct; 82(5):814-9. PubMed ID: 8885893
[TBL] [Abstract][Full Text] [Related]
32. Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease.
Pereira IR; Vilar-Pereira G; Silva AA; Lannes-Vieira J
Mem Inst Oswaldo Cruz; 2014 Jun; 109(3):289-98. PubMed ID: 24937048
[TBL] [Abstract][Full Text] [Related]
33. Abnormalities of the coronary microcirculation in acute murine Chagas' disease.
Factor SM; Cho S; Wittner M; Tanowitz H
Am J Trop Med Hyg; 1985 Mar; 34(2):246-53. PubMed ID: 3985268
[TBL] [Abstract][Full Text] [Related]
34. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
Hernández M; Wicz S; Corral RS
Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of histologic changes in Chagas' cardiomyopathy and dilated cardiomyopathy].
Barretto AC; Higuchi ML; da Luz PL; Lopes EA; Bellotti G; Mady C; Stolf N; Arteaga-Fernández E; Pileggi F
Arq Bras Cardiol; 1989 Feb; 52(2):79-83. PubMed ID: 2596992
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of neural cell adhesion molecule in Chagas' myocarditis.
Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB
Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701
[TBL] [Abstract][Full Text] [Related]
37. Trypanosoma cruzi Infection Induces Myocardial Nitric Oxide Synthase.
Huang Md H; Chan Md J; Wittner Md PhD M; Weiss Md Mph LM; Bacchi PhD J; Yarlett PhD N; Martinez Ba M; Morris Md PhD SA; Braunstein Bs VL; Factor Md SM; Tanowitz Md HB
Cardiovasc Pathol; 1997; 6(3):161-6. PubMed ID: 25850327
[TBL] [Abstract][Full Text] [Related]
38. Confirmation of Chagas' cardiomyopathy following heart transplantation.
Phan BA; Laflamme MA; Stempien-Otero A; Limaye AP; Buckner FS; Levy WC
Heart Vessels; 2006 Sep; 21(5):325-7. PubMed ID: 17151822
[TBL] [Abstract][Full Text] [Related]
39. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.
Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA
Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687
[TBL] [Abstract][Full Text] [Related]
40. [Magnetic resonance imaging in chronic Chagas cardiopathy. Correlation with endomyocardial biopsy findings].
Kalil R; Bocchi EA; Ferreira BM; de Lourdes Higuchi M; Lopes NH; Magalhães AC; Mady C; Pereira Barretto AC; Albuquerque CP; Bellotti G
Arq Bras Cardiol; 1995 Nov; 65(5):413-6. PubMed ID: 8729858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
